AGR2 and LYPD3 as breast cancer targets

DISEASE CATEGORY: Cancer

INDICATION: Breast cancer

Inhibiting the membrane receptor LYPD3 or its ligand AGR2 could treat endocrine therapy-resistant

Read the full 172 word article

User Sign In